Data mining for signal detection of adverse events for taxanes based on the food and drug administration adverse drug events reporting system database

Wang, Lin-Yu; Liao, Lin; Lei, Cai-Lu; Wu, Qiong; Guo, You-Jia; Li, Yan

doi:10.1080/14740338.2023.2203487

Expert Opinion on Drug Safety

2023

DOI: 10.1080/14740338.2023.2203487

|View full text |Cite

Data mining for signal detection of adverse events for taxanes based on the food and drug administration adverse drug events reporting system database

Lin-Yu Wang

Lin Liao

Cai-Lu Lei

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Data mining for signal detection of adverse events for taxanes based on the food and drug administration adverse drug events reporting system database

Cited by 2 publications

References 33 publications

Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system

Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system

Data mining and analysis of the adverse events derived signals of 4 gadolinium-based contrast agents based on the US Food and drug administration adverse event reporting system

Contact Info

Product

Resources

About